Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Laura, Varas"'
Autor:
Malin Lindstedt, Peter Ellmark, Lennart Greiff, Karin Hägerbrand, Laura von Schantz, Mia Thagesson, Doreen Werchau, Kristine Smedenfors, Anna Rosén, Anette Sundstedt, Adnan Deronic, Lill Ljung, Mattias Levin, Laura Varas, Anna Säll, Christina Sakellariou, Barnabas Nyesiga, David Gomez Jimenez, Mona Celander, Deniz Bölükbas, Fredrika Carlsson
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 11 (2022)
Background Indications with poor T-cell infiltration or deficiencies in T-cell priming and associated unresponsiveness to established immunotherapies represent an unmet medical need in oncology. CD40-targeting therapies designed to enhance antigen pr
Externí odkaz:
https://doaj.org/article/3ded16f9cf504c5983b33e362b58d5fd
Autor:
Peter Ellmark, Karin Hägerbrand, Mia Thagesson, Doreen Werchau, Anna Rosén, Karin Barchan, Anette Sundstedt, Adnan Deronic, Lill Ljung, Mattias Levin, Laura Von Schantz, Laura Varas, Anna Säll, Barnabas Nyesiga, Eva Lindqvist
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/9e6a3658910c424b887736939f0b115c
Autor:
Peter Ellmark, Karin Hägerbrand, Doreen Werchau, Anna Rosén, Karin Barchan, Adnan Deronic, Mattias Levin, Laura Von Schantz, Laura Varas, Anna Säll, Lill Ljug, Mia Thageson, Christina Sakellariou
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/bc293d52dd564f1e929282860de5f171
Autor:
Karin Hägerbrand, Anette Sundstedt, Mattias Levin, Yago Pico de Coaña, Laura Varas, Lill Ljung, Anneli Nilsson, Mona Celander, David Gomez Jimenez, Hampus Andersson, Malin Lindstedt, Peter Ellmark
Publikováno v:
Cancer Research. 83:2939-2939
Alligator’s Neo-X-Prime platform aims to enable antigen presenting cells to efficiently enhance priming of tumor neoantigen-specific T cells. We have demonstrated that binding of a CD40 x TAA bispecific antibody (bsAb) to CD40 on dendritic cells (D
Autor:
Barnabas Nyesiga, Mia Thagesson, Anna Rosén, Karin Hägerbrand, Mattias Levin, Karin Barchan, Laura Varas, Anette Sundstedt, Anna Säll, Doreen Werchau, Peter Ellmark, Lill Ljung, Laura Von Schantz, Eva Lindqvist, Adnan Deronic
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
BackgroundAlligator's Neo-X-Prime platform aims to enable antigen presenting cells to efficiently enhance priming of tumor neoantigen-specific T cells with the goal of overcoming PD-1 resistance in certain tumor types. We hypothesize that binding of
Autor:
Karin Hägerbrand, Laura Varas, Adnan Deronic, Barnabas Nyesiga, Anette Sundstedt, Lill Ljung, Christina Sakellariou, Doreen Werchau, Mia Thagesson, David Gomez Jimenez, Lennart Greiff, Mona Celander, Kristine Smedenfors, Anna Rosén, Deniz Bölükbas, Fredrika Carlsson, Mattias Levin, Anna Säll, Laura von Schantz, Malin Lindstedt, Peter Ellmark
Publikováno v:
Journal for ImmunoTherapy of Cancer. 10:e005018
BackgroundIndications with poor T-cell infiltration or deficiencies in T-cell priming and associated unresponsiveness to established immunotherapies represent an unmet medical need in oncology. CD40-targeting therapies designed to enhance antigen pre
Autor:
Yayrí C. Prieto, Aileen Batte, Milaid Granadillo, Miladys Limonta, Isis Torrens, Enma Brown, Dinorah Torres, Dayana Soler, Laura Varas, Alain B. Alfonso
Publikováno v:
Journal of Cellular Immunotherapy, Vol 4, Iss 2, Pp 71-74 (2018)
Cervical cancer is the second leading cause of cancer death in women. It is well established that human papillomavirus (HPV) is the cause of virtually 100% of these cancers, 70% of which are attributable to infections with HPV types 16 or 18. We deve
Autor:
Rosalina Carballo, José Suárez, Dayana Soler, Aileen Batte, Nelson Merino, Maelys Miyares, Miladys Limonta, Lizet Aldana, Aracelys Blanco, Milaid Granadillo, Isis Torrens, Laura Varas, Yayrí C. Prieto, Alain B. Alfonso, Bárbara González
Publikováno v:
Clinical & Experimental Metastasis. 34:241-249
One important goal of cancer immunotherapy is to prevent and treat tumor metastasis. We have previously reported the significant antitumor effect induced by the immunization with our human papillomavirus therapeutic protein-based vaccine (LALF32-51-E
Autor:
Maelys Miyares, Dioslaida Urquiza, Milaid Granadillo, Isis Torrens, Aracelys Blanco, Dayana Soler, Aileen Batte, Miladys Limonta, Laura Varas, Alain B. Alfonso
Publikováno v:
Vaccine. 37(30)
Cervical cancer is a global public health problem and human papillomavirus (HPV) 16 accounts for approximately 50% of cases worldwide. Although there are several types of HPV therapeutic vaccines in clinical research, there are currently not approved
Autor:
Miladys Limonta, Laura Varas, Jorge Valdés, Lourdes Zumalacárregui, Dayana Soler, Maelys Miyares, Alain Alfonso, Milaid Granadillo, Isis Torrens
Publikováno v:
BioProcessing Journal. 14:22-29